2019 International Congress

Wednesday, September 25, 2019

1:15pm-2:45pm

Humming bird sign in craniovertebral junction anomaly leading to misdiagnosis of progressive supranuclear palsy

D. Desai, D. Pandya, S. Desai (Anand, India)

Neuroimaging  ·  Les Muses Terrace, Level 3

1:15pm-2:45pm

Hypermethylation of PGC-1α in peripheral blood leukocytes of patients with Parkinson’s disease

X. Yang, SQ. Xu, W. Qian, Q. Xiao (Shanghai, China)

Physiology and Pathophysiology  ·  Les Muses, Level 3

1:15pm-2:45pm

Hyposmia as a marker of (non-)motor disease progression in Parkinson’s disease

D. Roos, J. Twisk, P. Raijmakers, R. Doty, H. Berendse (Amsterdam, Netherlands)

Non-Motor Symptoms  ·  Agora 3 West, Level 3

1:15pm-2:45pm

Identification and Characterization of Selective and High Affinity Small Molecules as Positron Emission Tomography (PET) Imaging Tracers for Pathological Alpha-Synuclein

E. Tsika, E. Vokali, J. Molette, M. Ravache, P. Rodriguez, V. Darmency, K. Piorkowska, S. Poli, H. Kroth, F. Capotosti, D. Lowe, J. Stoehr, M. Kosco-Vilbois, A. Pfeifer, A. Muhs (Lausanne, Switzerland)

Neuroimaging  ·  Les Muses Terrace, Level 3

1:15pm-2:45pm

Identifying altered resting state network connectivity in Parkinson’s disease with mild cognitive impairment

J. Yang, K. Mcmahon, D. Copland, G. Byrne, J. O'Sullivan, N. Dissanayaka (Herston, Australia)

Neuroimaging  ·  Les Muses Terrace, Level 3

1:15pm-2:45pm

Identifying delirium in people with Parkinson’s disease: the Determine-PD pilot study

R. Lawson, S. Richardson, A. Yarnall, D. Burn, L. Allan (Newcastle Upon Tyne, United Kingdom)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3

1:15pm-2:45pm

Identifying subtypes of Mild Cognitive Impairment in Parkinson’s disease using cluster analysis

D. Pourzinal, JH. Yang, G. Byrne, J. O'Sullivan, L. Mitchell, K. Mcmahon, D. Copland, N. Dissanayaka (St Lucia, Australia)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3

1:15pm-2:45pm

Imaging biomarker for progression of motor symptoms in advanced Parkinson’s disease

K. Furukawa, N. Sawamoto, A. Shima, D. Kambe, A. Nishida, I. Wada, H. Sakamaki, K. Yoshimura, Y. Fushimi, T. Okada, K. Togashi, R. Takahashi (Kyoto, Japan)

Neuroimaging  ·  Les Muses Terrace, Level 3

1:15pm-2:45pm

Imaging Brain Insulin Resistance in Parkinson’s Disease using [¹⁸F]FDG-PET

E. Hogg, P. Linesch, T. Wu, E. Tan, Z. Fan, W. Gao, A. Waxman, M. Tagliati (Los Angeles, CA, USA)

Neuroimaging  ·  Les Muses Terrace, Level 3

1:15pm-2:45pm

Imaging correlates of impaired self-awareness of cognitive deficits in Parkinson’s disease

F. Maier, A. Greuel, M. Hoock, M. Tahmasian, F. Jessen, I. Csoti, L. Timmermann, C. Eggers (Cologne, Germany)

Neuroimaging  ·  Les Muses Terrace, Level 3